MISSION AND OVERVIEW

PANACEA Natural Sciences, Inc. is a holding company dedicated to bringing innovative medical cannabis products and technologies from Israel to global business and consumer markets. The British Columbia based C corporation’s mission is to identify and invest in new medical cannabis companies that deliver effective treatments and delivery systems which dramatically improve quality of life across a wide variety of medical indications. PANACEA has partnered with Israeli leaders in medical cannabis treatments and technologies who currently lack the resources to effectively, efficiently and legally reach global markets.

PANACEA medical cannabis products serve the global nutraceuticals market, which according to ResearchAndMarkets.com approached $380 billion last year and is expected to reach $734 billion by 2026. Fueled by an aging global population, the increase in health disorders and healthcare costs are driving consumers to alternative nutrient based solutions including medical cannabis products.

What sets PANACEA apart from the competition in this growing market are its established relationships with leading cannabis research, technology and product development firms in Israel. In the early 1990s, Israel legalized medical cannabis for cancer patients and those with other chronic illnesses and has since led the market in cultivation, technology, genetic strains and clinically/patient tested remedies and delivery methodologies.

Market demand is accelerating and yet these Israeli leaders in medical cannabis treatments and technologies lack the resources to effectively, efficiently and legally reach global markets. PANACEA is uniquely positioned to fill this void with a scalable business model, established relationships with cannabis wellness businesses and global industry expertise.